BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 28731842)

  • 1. Role of Pepsin and Oropharyngeal pH-Monitoring to Assess the Postoperative Outcome of Patients with Laryngopharyngeal Reflux: Results of a Pilot Trial.
    Weitzendorfer M; Pfandner R; Antoniou SA; Langsteger W; Witzel K; Emmanuel K; Koch OO
    J Laparoendosc Adv Surg Tech A; 2017 Sep; 27(9):937-943. PubMed ID: 28731842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux.
    Weitzendorfer M; Antoniou SA; Schredl P; Witzel K; Weitzendorfer IC; Majerus A; Emmanuel K; Koch OO
    Laryngoscope; 2020 Jul; 130(7):1780-1786. PubMed ID: 31603541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes.
    Bobin F; Journe F; Lechien JR
    Laryngoscope; 2020 May; 130(5):1278-1281. PubMed ID: 31461170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of salivary and nasal lavage pepsin with MII-pH testing.
    Klimara MJ; Johnston N; Samuels TL; Visotcky AM; Poetker DM; Loehrl TA; Blumin JH; Bock JM
    Laryngoscope; 2020 Apr; 130(4):961-966. PubMed ID: 31329290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nissen fundoplication
    Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
    World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nissen Fundoplication for Laryngopharyngeal Reflux After Patient Selection Using Dual pH, Full Column Impedance Testing: A Pilot Study.
    Carroll TL; Nahikian K; Asban A; Wiener D
    Ann Otol Rhinol Laryngol; 2016 Sep; 125(9):722-8. PubMed ID: 27217426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Pepsin Saliva Concentration (Peptestâ„¢) Predict the Therapeutic Response of Laryngopharyngeal Reflux Patients?
    Lechien JR; Bobin F; Dequanter D; Rodriguez A; Le Bon S; Horoi M; Thill MP; Salem C; Muls V; Saussez S
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):996-1003. PubMed ID: 33467863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin?
    Spyridoulias A; Lillie S; Vyas A; Fowler SJ
    Respir Med; 2015 Aug; 109(8):963-9. PubMed ID: 26044812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients.
    Fortunato JE; D'Agostino RB; Lively MO
    Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27604397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux.
    Na SY; Kwon OE; Lee YC; Eun YG
    Laryngoscope; 2016 Dec; 126(12):2770-2773. PubMed ID: 27075393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study.
    Sereg-Bahar M; Jerin A; Jansa R; Stabuc B; Hocevar-Boltezar I
    Clin Otolaryngol; 2015 Jun; 40(3):234-9. PubMed ID: 25516364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Utility of Salivary Pepsin as Compared With 24-Hour Dual pH/Impedance Probe in Laryngopharyngeal Reflux.
    Zhang M; Chia C; Stanley C; Phyland DJ; Paddle PM
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):375-380. PubMed ID: 32895009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Pepsin in the Saliva and the Subjective Symptoms in Patients With Laryngopharyngeal Reflux.
    Jung AR; Kwon OE; Park JM; Dong SH; Jung SY; Lee YC; Eun YG
    J Voice; 2019 Mar; 33(2):150-154. PubMed ID: 29174850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPR: how different diagnostic tools shape the outcomes of treatment.
    Wan Y; Yan Y; Ma F; Wang L; Lu P; Maytag A; Jiang JJ
    J Voice; 2014 May; 28(3):362-8. PubMed ID: 24491501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic value of pepsin concentration in saliva for laryngopharyngeal reflux disease.
    Yu L; Li R; Du L; Zhao Y
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5783-5789. PubMed ID: 35689682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux.
    Wang CP; Wang CC; Lien HC; Lin WJ; Wu SH; Liang KL; Liu SA
    Laryngoscope; 2019 Mar; 129(3):709-714. PubMed ID: 30247754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation analysis between Dx-pH monitoring and proton pump inhibitor test in the diagnosis of laryngopharyngeal reflux disease].
    Chen ZL; Wu HW; Mei XW; Yin WH; Xu SY; Liu SQ; Chen YC; Wang G; Zhang CJ; Ding XL; Wu JN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):34-39. PubMed ID: 31954386
    [No Abstract]   [Full Text] [Related]  

  • 19. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.
    Du X; Wang F; Hu Z; Wu J; Wang Z; Yan C; Zhang C; Tang J
    BMC Gastroenterol; 2017 Oct; 17(1):107. PubMed ID: 29041918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Peptestâ„¢ in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing.
    Bor S; Capanoglu D; Vardar R; Woodcock AD; Fisher J; Dettmar PW
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):383-387. PubMed ID: 31826051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.